Brazil will test psychedelic mushrooms to create medicine

The research will evaluate the quantity and psychoactive components and test the potency (level of psilocin and psilocybin) of the psychedelic for end-use in patients in Brazil.

RIO DE JANEIRO, BRAZIL - A pioneering study for the development of medicines derived from psychedelics will be carried out by a public laboratory in Brazil, according to researchers from the Laboratory for Evaluation and Development of Biomaterials in the Northeast (Certbio) of the Federal University of Campina Grande (UFCG).

Due to its enormous technological potential, the laboratory, which has become known as the Silicon Valley of the countryside, has just received authorization from the National Health Surveillance Agency (Anvisa . . .

To read the full NEWS and much more, Subscribe to our Premium Membership Plan. Already Subscribed?